“…Computational methods and systems biology approaches can play key roles in the discovery of suitable drugs. Constraint-based modeling (CBM) has been successfully applied in fundamental research [13] , [14] , [15] , the inference of oncogenes [16] , [17] , [18] , [19] , [20] , [21] , [22] , the discovery of anticancer targets [23] , [24] , [25] , [26] in oncology, microbial engineering [27] , [28] , [29] , and other research fields. CBM uses data- and knowledge-driven constraints to identify feasible metabolic flux distributions for a given condition [ 13 , 14 ].…”